Sciwind has granted Verdiva the exclusive global rights to develop, manufacture and commercialize the partnered programs outside of greater China and South Korea. Sciwind has retained the rights to ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...

Highmark Health President and CEO David Holmberg discussed the uncertainties facing the insurance industry, including the ...

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Explore how inhibiting myostatin can promote muscle mass in men, addressing sarcopenia, GLP-1 medication effects, and aging ...